Alaunos Therapeutics (TCRT) EBT Margin (2016 - 2025)
Historic EBT Margin for Alaunos Therapeutics (TCRT) over the last 13 years, with Q1 2025 value amounting to 54600.0%.
- Alaunos Therapeutics' EBT Margin rose 1196000000.0% to 54600.0% in Q1 2025 from the same period last year, while for Sep 2025 it was 67883.33%, marking a year-over-year increase of 1322333300.0%. This contributed to the annual value of 48120.0% for FY2024, which is 6756400000.0% up from last year.
- Per Alaunos Therapeutics' latest filing, its EBT Margin stood at 54600.0% for Q1 2025, which was up 1196000000.0% from 18875.0% recorded in Q4 2024.
- In the past 5 years, Alaunos Therapeutics' EBT Margin ranged from a high of 312.78% in Q3 2022 and a low of 794900.0% during Q4 2023
- In the last 5 years, Alaunos Therapeutics' EBT Margin had a median value of 70122.73% in 2025 and averaged 197999.68%.
- Its EBT Margin has fluctuated over the past 5 years, first plummeted by 2000000000bps in 2023, then surged by 2000000000bps in 2024.
- Over the past 5 years, Alaunos Therapeutics' EBT Margin (Quarter) stood at 590350.0% in 2021, then surged by 85bps to 85645.45% in 2022, then crashed by -828bps to 794900.0% in 2023, then soared by 98bps to 18875.0% in 2024, then tumbled by -189bps to 54600.0% in 2025.
- Its EBT Margin stands at 54600.0% for Q1 2025, versus 18875.0% for Q4 2024 and 29150.0% for Q2 2024.